Konkurrencejura

  • Om konkurrencejura
  • Cookie- og privatlivspolitik

Sudden Price Spikes in Off-Patent Prescription Drugs: The Monopoly Business Model that Harms Patients, Taxpayers, and the U.S. Health Care System

by kennett.cphd | Dec 1, 2016

In November 2015, Chairman Susan Collins (R-Maine) and Ranking Member Claire McCaskill (D-Missouri) launched a bipartisan Senate Special Committee on Aging investigation of abrupt and dramatic price increases in prescription drugs whose patents had expired long ago....

Seneste indlæg

    Seneste kommentarer

    No comments to show.